Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Relationship of epitope glycosylation and other properties of blood group proteins to the immunogenicity of blood group antigens.

Howe JG, Stack G.

Transfusion. 2018 Jul;58(7):1739-1751. doi: 10.1111/trf.14609. Epub 2018 May 16.

PMID:
29770450
2.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.

Flegel WA, Chen Q, Castilho L, Keller MA, Klapper EB, Lane WJ, Pirenne F, Stack G, St-Louis M, Tormey CA, Waxman DA, Weinstock C, Wendel S, Denomme GA.

Blood Transfus. 2018 Sep;16(5):447-456. doi: 10.2450/2018.0260-17. Epub 2018 Feb 14. No abstract available.

3.

Author Correction: Evolution of host adaptation in the Salmonella typhoid toxin.

Gao X, Deng L, Stack G, Yu H, Chen X, Naito-Matsui Y, Varki A, Galán JE.

Nat Microbiol. 2017 Dec;2(12):1697. doi: 10.1038/s41564-017-0070-x.

PMID:
29093550
4.

Evolution of host adaptation in the Salmonella typhoid toxin.

Gao X, Deng L, Stack G, Yu H, Chen X, Naito-Matsui Y, Varki A, Galán JE.

Nat Microbiol. 2017 Dec;2(12):1592-1599. doi: 10.1038/s41564-017-0033-2. Epub 2017 Oct 9. Erratum in: Nat Microbiol. 2017 Dec;2(12 ):1697.

5.

The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis.

Stacey MA, Clare S, Clement M, Marsden M, Abdul-Karim J, Kane L, Harcourt K, Brandt C, Fielding CA, Smith SE, Wash RS, Brias SG, Stack G, Notley G, Cambridge EL, Isherwood C, Speak AO, Johnson Z, Ferlin W, Jones SA, Kellam P, Humphreys IR.

J Clin Invest. 2017 Apr 3;127(4):1463-1474. doi: 10.1172/JCI84889. Epub 2017 Feb 27.

6.

Emerging insights into the biology of typhoid toxin.

Fowler CC, Chang SJ, Gao X, Geiger T, Stack G, Galán JE.

Curr Opin Microbiol. 2017 Feb;35:70-77. doi: 10.1016/j.mib.2017.01.012. Epub 2017 Feb 16. Review.

7.

Structural and functional impacts of amino acid substitutions that create blood group antigens: implications for immunogenicity.

Howe JG, Stack G.

Transfusion. 2017 Mar;57(3):541-553. doi: 10.1111/trf.13966. Epub 2017 Feb 5.

PMID:
28164302
8.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015.

Flegel WA, Castilho L, Heaton WA, Keller MA, Klapper EB, Lane WJ, Pirenne F, Shehata N, Stack G, St-Louis M, Tormey CA, Wagner FF, Waxman DA, Denomme GA.

Blood Transfus. 2016 Nov;14(6):557-565. doi: 10.2450/2016.0063-16. Epub 2016 Jul 29. No abstract available.

9.

Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence.

Stack G, Tormey CA.

Transfusion. 2016 Nov;56(11):2662-2667. doi: 10.1111/trf.13704. Epub 2016 Jul 9.

PMID:
27394029
10.

Estimating the immunogenicity of blood group antigens: a modified calculation that corrects for transfusion exposures.

Stack G, Tormey CA.

Br J Haematol. 2016 Oct;175(1):154-60. doi: 10.1111/bjh.14175. Epub 2016 Jun 24.

PMID:
27340943
11.

The Role of IL-22 in Viral Infections: Paradigms and Paradoxes.

Gimeno Brias S, Stack G, Stacey MA, Redwood AJ, Humphreys IR.

Front Immunol. 2016 May 30;7:211. doi: 10.3389/fimmu.2016.00211. eCollection 2016.

12.
13.

Fluid motion and shear forces in platelet storage bags with different modes of agitation.

Torres R, Tormey CA, Stack G.

Vox Sang. 2016 Aug;111(2):209-12. doi: 10.1111/vox.12409. Epub 2016 Apr 14.

14.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Philadelphia 2014.

Flegel WA, De Castilho SL, Keller MA, Klapper EB, Moulds JM, Noizat-Pirenne F, Shehata N, Stack G, St-Louis M, Tormey CA, Waxman DA, Weinstock C, Wendel S, Denomme GA.

Blood Transfus. 2016 Sep;14(5):425-33. doi: 10.2450/2015.0130-15. Epub 2015 Dec 21. No abstract available.

15.

CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue.

Stack G, Jones E, Marsden M, Stacey MA, Snelgrove RJ, Lacaze P, Jacques LC, Cuff SM, Stanton RJ, Gallimore AM, Hussell T, Wilkinson GW, Ghazal P, Taylor PR, Humphreys IR.

PLoS Pathog. 2015 Feb 5;11(2):e1004641. doi: 10.1371/journal.ppat.1004641. eCollection 2015 Feb.

16.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Denver 2013.

Flegel WA, Castilho L, Delaney M, Klapper EB, Moulds JM, Noizat-Pirenne F, Shehata N, Stack G, Tormey CA, Wagner FF, Waxman DA, Weinstock C, Wendel S, Denomme GA.

Blood Transfus. 2015 Jul;13(3):514-20. doi: 10.2450/2014.0213-14. Epub 2014 Dec 2. No abstract available.

17.

Platelet transfusion: a clinical practice guideline from the AABB.

Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, Cipolle MD, Cohn CS, Fung MK, Grossman BJ, Mintz PD, O'Malley BA, Sesok-Pizzini DA, Shander A, Stack GE, Webert KE, Weinstein R, Welch BG, Whitman GJ, Wong EC, Tobian AA; AABB.

Ann Intern Med. 2015 Feb 3;162(3):205-13. doi: 10.7326/M14-1589.

PMID:
25383671
18.

Use of a cytokine-release assay to demonstrate loss of platelet secretory capacity during blood bank processing and storage.

Tormey CA, Stack G.

Arch Pathol Lab Med. 2014 Nov;138(11):1481-7. doi: 10.5858/arpa.2013-0680-OA.

PMID:
25357109
19.

Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV.

Stacey MA, Marsden M, Pham N TA, Clare S, Dolton G, Stack G, Jones E, Klenerman P, Gallimore AM, Taylor PR, Snelgrove RJ, Lawley TD, Dougan G, Benedict CA, Jones SA, Wilkinson GW, Humphreys IR.

Cell Host Microbe. 2014 Apr 9;15(4):471-83. doi: 10.1016/j.chom.2014.03.003.

20.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Boston 2012.

Flegel WA, Johnson ST, Keller MA, Klapper EB, Khuu HM, Moulds JM, Seltsam AW, Stack G, St-Louis M, Tormey CA, Wagner FF, Weinstock C, Yazer MH, Denomme GA.

Blood Transfus. 2014 Apr;12(2):280-6. doi: 10.2450/2013.0022-13. Epub 2013 Oct 18. No abstract available.

21.

Limiting the extent of a delayed hemolytic transfusion reaction with automated red blood cell exchange.

Tormey CA, Stack G.

Arch Pathol Lab Med. 2013 Jun;137(6):861-4. doi: 10.5858/arpa.2012-0154-CR.

PMID:
23721278
22.

Record fragmentation due to transfusion at multiple health care facilities: a risk factor for delayed hemolytic transfusion reactions.

Unni N, Peddinghaus M, Tormey CA, Stack G.

Transfusion. 2014 Jan;54(1):98-103. doi: 10.1111/trf.12251. Epub 2013 May 27.

PMID:
23711236
23.

Herpesvirus exploitation of host immune inhibitory pathways.

Stack G, Stacey MA, Humphreys IR.

Viruses. 2012 Aug;4(8):1182-201. Epub 2012 Aug 3. Review.

24.

Optimising the delivery of tubulin targeting agents through antibody conjugation.

Stack GD, Walsh JJ.

Pharm Res. 2012 Nov;29(11):2972-84. doi: 10.1007/s11095-012-0810-9. Epub 2012 Jul 10. Review.

PMID:
22777294
25.

Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.

Dunlop J, Watts SW, Barrett JE, Coupet J, Harrison B, Mazandarani H, Nawoschik S, Pangalos MN, Ramamoorthy S, Schechter L, Smith D, Stack G, Zhang J, Zhang G, Rosenzweig-Lipson S.

J Pharmacol Exp Ther. 2011 Jun;337(3):673-80. doi: 10.1124/jpet.111.179572. Epub 2011 Mar 14.

PMID:
21402690
26.

Pathology consultation on warfarin pharmacogenetic testing.

Stack G; Education Committee of the Academy of Clinical Laboratory Physicians and Scientists.

Am J Clin Pathol. 2011 Jan;135(1):13-9. doi: 10.1309/AJCPAO82OTNPUBLW. No abstract available.

PMID:
21173120
27.

Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping.

Maurice CB, Barua PK, Simses D, Smith P, Howe JG, Stack G.

Clin Chim Acta. 2010 Jul 4;411(13-14):947-54. doi: 10.1016/j.cca.2010.03.005. Epub 2010 Mar 11.

PMID:
20226775
28.

The dopamine D(2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopa.

Jackson MJ, Andree TH, Hansard M, Hoffman DC, Hurtt MR, Kehne JH, Pitler TA, Smith LA, Stack G, Jenner P.

J Neural Transm (Vienna). 2010 Jan;117(1):55-67. doi: 10.1007/s00702-009-0323-9. Epub 2009 Oct 7.

PMID:
19809864
29.

Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists.

Zhou D, Stack GP, Lo J, Failli AA, Evrard DA, Harrison BL, Hatzenbuhler NT, Tran M, Croce S, Yi S, Golembieski J, Hornby GA, Lai M, Lin Q, Schechter LE, Smith DL, Shilling AD, Huselton C, Mitchell P, Beyer CE, Andree TH.

J Med Chem. 2009 Aug 13;52(15):4955-9. doi: 10.1021/jm900374r.

PMID:
19719241
30.
31.

The characterization and classification of concurrent blood group antibodies.

Tormey CA, Stack G.

Transfusion. 2009 Dec;49(12):2709-18. doi: 10.1111/j.1537-2995.2009.02337.x. Epub 2009 Aug 4.

PMID:
19682334
32.

5-HT(1A) receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats.

Sukoff Rizzo SJ, Pulicicchio C, Malberg JE, Andree TH, Stack GP, Hughes ZA, Schechter LE, Rosenzweig-Lipson S.

Int J Neuropsychopharmacol. 2009 Sep;12(8):1045-53. doi: 10.1017/S1461145709000406. Epub 2009 May 13.

PMID:
19435548
34.

Drug-induced thrombocytopenia.

Kenney B, Stack G.

Arch Pathol Lab Med. 2009 Feb;133(2):309-14. doi: 10.1043/1543-2165-133.2.309. Review.

PMID:
19195976
35.
36.

WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics.

Grauer SM, Graf R, Navarra R, Sung A, Logue SF, Stack G, Huselton C, Liu Z, Comery TA, Marquis KL, Rosenzweig-Lipson S.

Psychopharmacology (Berl). 2009 May;204(1):37-48. doi: 10.1007/s00213-008-1433-z. Epub 2008 Dec 20.

PMID:
19107466
37.

alpha1-Antitrypsin deficiency is a possible first event in the two-event model of transfusion-related acute lung injury: a proposal and case report.

Stack G, Tormey CA.

Transfusion. 2008 Nov;48(11):2477-8. doi: 10.1111/j.1537-2995.2008.01875.x. No abstract available.

PMID:
19054378
38.

The persistence and evanescence of blood group alloantibodies in men.

Tormey CA, Stack G.

Transfusion. 2009 Mar;49(3):505-12. doi: 10.1111/j.1537-2995.2008.02014.x. Epub 2008 Nov 24.

PMID:
19040411
39.

Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.

Tormey CA, Fisk J, Stack G.

Transfusion. 2008 Oct;48(10):2069-76. doi: 10.1111/j.1537-2995.2008.01815.x. Epub 2008 Jul 9.

PMID:
18631165
40.

Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.

Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC.

J Med Chem. 2008 Jul 10;51(13):4038-49. doi: 10.1021/jm8002262. Epub 2008 Jun 17.

PMID:
18557608
41.

Blood product replacement in the perinatal period.

Wu Y, Stack G.

Semin Perinatol. 2007 Aug;31(4):262-71.

PMID:
17825684
42.

Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter.

Mason JN, Deecher DC, Richmond RL, Stack G, Mahaney PE, Trybulski E, Winneker RC, Blakely RD.

J Pharmacol Exp Ther. 2007 Nov;323(2):720-9. Epub 2007 Aug 2.

PMID:
17673606
43.

Resident and fellow training in transfusion medicine.

Wu Y, Tormey C, Stack G.

Clin Lab Med. 2007 Jun;27(2):293-342; abstract vii. Review.

PMID:
17556087
44.

Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT1A receptor.

Zhou D, Hatzenbuhler NT, Gross JL, Harrison BL, Evrard DA, Chlenov M, Golembieski J, Hornby G, Schechter LE, Smith DL, Andree TH, Stack GP.

Bioorg Med Chem Lett. 2007 Jun 1;17(11):3117-21. Epub 2007 Mar 19.

PMID:
17407811
45.

Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents.

Rosenzweig-Lipson S, Sabb A, Stack G, Mitchell P, Lucki I, Malberg JE, Grauer S, Brennan J, Cryan JF, Sukoff Rizzo SJ, Dunlop J, Barrett JE, Marquis KL.

Psychopharmacology (Berl). 2007 Jun;192(2):159-70. Epub 2007 Feb 13.

PMID:
17297636
46.

Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.

Heinrich JN, Brennan J, Lai MH, Sullivan K, Hornby G, Popiolek M, Jiang LX, Pausch MH, Stack G, Marquis KL, Andree TH.

Eur J Pharmacol. 2006 Dec 15;552(1-3):36-45. Epub 2006 Sep 14.

PMID:
17056032
47.

WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.

Marquis KL, Sabb AL, Logue SF, Brennan JA, Piesla MJ, Comery TA, Grauer SM, Ashby CR Jr, Nguyen HQ, Dawson LA, Barrett JE, Stack G, Meltzer HY, Harrison BL, Rosenzweig-Lipson S.

J Pharmacol Exp Ther. 2007 Jan;320(1):486-96. Epub 2006 Oct 12.

PMID:
17038512
48.

Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.

Rosenzweig-Lipson S, Zhang J, Mazandarani H, Harrison BL, Sabb A, Sabalski J, Stack G, Welmaker G, Barrett JE, Dunlop J.

Brain Res. 2006 Feb 16;1073-1074:240-51. Epub 2006 Jan 20.

PMID:
16430874
49.

WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity.

Dunlop J, Sabb AL, Mazandarani H, Zhang J, Kalgaonker S, Shukhina E, Sukoff S, Vogel RL, Stack G, Schechter L, Harrison BL, Rosenzweig-Lipson S.

J Pharmacol Exp Ther. 2005 May;313(2):862-9. Epub 2005 Feb 10.

PMID:
15705738
50.

Modulation of selective serotonin reuptake inhibitor and 5-HT1A antagonist activity in 8-aza-bicyclo[3.2.1]octane derivatives of 2,3-dihydro-1,4-benzodioxane.

Gilbert AM, Stack GP, Nilakantan R, Kodah J, Tran M, Scerni R, Shi X, Smith DL, Andree TH.

Bioorg Med Chem Lett. 2004 Jan 19;14(2):515-8.

PMID:
14698193

Supplemental Content

Support Center